Recro Pharma Inc (USD)
REPH
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range16.29 | 16.55
52-Wk Range4.96 | 17.36
Last Close16.25
Mkt Cap (m)369.37
Dividend yield-
ISINUS75629F1093
Volume72,874
Exchange VenueNAS

Company Profile

Recro Pharma Inc is a specialty pharmaceutical company. It develops non-opioid products for treatment of serious acute pain. The Company operates through two business divisions: Acute Care division and contract development and manufacturing division.

Key Information
Price/Earning-
Price/Book0.00
Price/Sales3.61
P/CF-
Rev Growth (3 year avg)14.19
EPS Growth (3 year avg)-
Operating Margin % -69.50
Net Margin %-103.07
Return on Equity-1705.67
Debt/Equity-

Legal Documents

Prospectus
en 19/02/2019
Annual Report
en 31/12/2018

Financials

Income Statement
USD201320142015201620172018
Revenue (m)52697277
Operating Income (m)-1-12-3-16-27-54
Net Income (m)-2-163-30-50-80
Basic EPS-0.35-2.790.36-2.82-2.63-3.90
Avg. Diluted Shares Outstanding (m)369111920
Balance Sheet
USD201320142015201620172018
Current Assets (m)12039858771
Non Current Assets (m)100989984
Total Assets (m)120139183186155
Current Liabilities (m)119165029
Total Liabilities (m)------
Total Equity (m)19407229-20
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)-1-118-3-17-43
Capital Expenditure (m)---2-4-7-11
Figures are quoted in USD unless stated otherwise
0.23 (1.42%)
$
16.48
Last Price